Owner-reported outcomes indicate intra-articular 2.5% polyacrylamide hydrogel injection is well tolerated and reduces osteoarthritis signs in dogs
These findings support further investigation of 2.5% iPAAG as a targeted therapy for canine OA. Controlled, prospective studies are needed to confirm its clinical efficacy.
Authors
- David Levine (ORCID: https://orcid.org/0000-0001-6712-5367)
- Jennifer A. Barnhard (ORCID: https://orcid.org/0000-0002-5486-8660)
- Matthew W. Brunke (ORCID: https://orcid.org/0000-0001-5923-0001)
- Ashley A. Tringali
- Abigail B. Shoben (ORCID: https://orcid.org/0000-0001-9347-4755)
- Arielle Pechette Markley (ORCID: https://orcid.org/0000-0003-2704-9931)
- Nancy J. Caldwell
- Megan M. Green
- Kathryn R. Webb
Institutions
- University of Tennessee at Chattanooga (US)
- Ta Solutions (China) (CN)
- Conservation Science Partners (US)
- MDS Associates (United States) (US)
- The Ohio State University (US)
- Franklin University (US)
Publication Details
- Journal
- Journal of the American Veterinary Medical Association
- Published
- 2025-09-24
- DOI
- https://doi.org/10.2460/javma.25.06.0398
- Citations
- 1
- Primary Topic
- Veterinary Orthopedics and Neurology
- Type
- article
- Field-Weighted Citation Impact
- 2.35